What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Fabrice Andre mainly investigates Internal medicine, Breast cancer, Oncology, Cancer and Cancer research.
His Internal medicine research focuses on Surgery and how it relates to Disease, Gastroenterology and Intensive care medicine.
His Breast cancer research incorporates themes from Chemotherapy regimen and Metastasis.
His study in Oncology is interdisciplinary in nature, drawing from both Chemotherapy, Tumor-infiltrating lymphocytes, Retrospective cohort study, Pathology and Triple-negative breast cancer.
His work carried out in the field of Cancer brings together such families of science as Clinical trial and Bioinformatics.
His Cancer research research also works with subjects such as
- Immunology that intertwine with fields like Radiation therapy,
- Immune system which is related to area like Cancer cell,
- Receptor which intersects with area such as Progression-free survival.
His most cited work include:
- Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. (2103 citations)
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 (1828 citations)
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer (1820 citations)
What are the main themes of his work throughout his whole career to date?
Fabrice Andre spends much of his time researching Internal medicine, Oncology, Breast cancer, Cancer and Cancer research.
His Internal medicine study typically links adjacent topics like Pathology.
His Oncology course of study focuses on Fulvestrant and Palbociclib.
In Breast cancer, Fabrice Andre works on issues like Bioinformatics, which are connected to Targeted therapy.
Fabrice Andre combines subjects such as Clinical endpoint and Pharmacology with his study of Cancer.
Fabrice Andre has researched Cancer research in several fields, including Cancer cell, Immunology, Immune system and PI3K/AKT/mTOR pathway.
He most often published in these fields:
- Internal medicine (61.06%)
- Oncology (53.82%)
- Breast cancer (50.63%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (61.06%)
- Oncology (53.82%)
- Breast cancer (50.63%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Oncology, Breast cancer, Cancer and Cancer research are his primary areas of study.
His research integrates issues of Pembrolizumab, Open label, Clinical trial and Triple-negative breast cancer in his study of Oncology.
The concepts of his Clinical trial study are interwoven with issues in Precision medicine and Immune system.
His Breast cancer research integrates issues from Odds ratio, Weight loss, Hazard ratio, Prospective cohort study and Cohort.
In general Cancer, his work in Fulvestrant and Advanced breast is often linked to Patient-reported outcome and Effective management linking many areas of study.
His Cancer research research is multidisciplinary, incorporating elements of PI3K/AKT/mTOR pathway, Antibody, Drug resistance and Osimertinib.
Between 2019 and 2021, his most popular works were:
- Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer (222 citations)
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. (164 citations)
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. (164 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Fabrice Andre focuses on Internal medicine, Breast cancer, Oncology, Cancer and Cancer research.
His work in the fields of Adverse effect, Cohort and Clinical endpoint overlaps with other areas such as Clinical Practice.
When carried out as part of a general Breast cancer research project, his work on Metastatic breast cancer is frequently linked to work in Educational resources, therefore connecting diverse disciplines of study.
His Oncology research incorporates themes from Pembrolizumab, Clinical trial, Chemotherapy, Predictive biomarker and Triple-negative breast cancer.
His research investigates the connection with Cancer and areas like Disease which intersect with concerns in Ensemble learning, Medical imaging and Intensive care unit.
His Cancer research research is multidisciplinary, relying on both Receptor, Human leukocyte antigen, Hormone receptor and Locus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
